{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:26:43Z","timestamp":1784723203597,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Nordic and Taiho Pharmaceuticals"},{"DOI":"10.13039\/501100001661","name":"University of Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.suronc.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T23:15:13Z","timestamp":1498691713000},"page":"177-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1260-5771","authenticated-orcid":false,"given":"Leila","family":"Sisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Nienh\u00fcser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg Martin","family":"Haag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-3675","authenticated-orcid":false,"given":"Thomas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.suronc.2017.06.001_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jamcollsurg.2005.05.033","article-title":"Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer?","volume":"201","author":"Bennett","year":"2005","journal-title":"J.\u00a0Am. Coll. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","article-title":"Patterns of initial recurrence in completely resected gastric adenocarcinoma","volume":"240","author":"D'Angelica","year":"2004","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2017.06.001_bib3","first-page":"235","article-title":"Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study","volume":"39","author":"Honore","year":"2013","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2017.06.001_bib4","first-page":"1479","article-title":"Review of clinical investigation on recurrence of gastric cancer following curative resection","volume":"125","author":"Li","year":"2012","journal-title":"Chin. Med. J."},{"issue":"4","key":"10.1016\/j.suronc.2017.06.001_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00261-008-9424-4","article-title":"Detecting recurrence of gastric cancer: the value of FDG PET\/CT","volume":"34","author":"Park","year":"2009","journal-title":"Abdom. imaging"},{"issue":"4","key":"10.1016\/j.suronc.2017.06.001_bib6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF02573875","article-title":"Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy","volume":"9","author":"Schwarz","year":"2002","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2017.06.001_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1746.2011.06919.x","article-title":"18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis","volume":"27","author":"Wu","year":"2012","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.suronc.2017.06.001_bib8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/bjc.2011.175","article-title":"Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma","volume":"104","author":"Fields","year":"2011","journal-title":"Br. J. cancer"},{"issue":"7","key":"10.1016\/j.suronc.2017.06.001_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3109\/0284186X.2012.673732","article-title":"Gekid Cancer Survival Working G. Survival of stomach and esophagus cancer patients in Germany in the early 21st century","volume":"51","author":"Hiripi","year":"2012","journal-title":"Acta Oncol."},{"key":"10.1016\/j.suronc.2017.06.001_bib10","unstructured":"Kaatsch DP, Spix DC, Katalinic PDA, Hentschel DS, Luttmann DS, Stegmaier C, Caspritz DS, Christ DM, Ernst DA, Folkerts DJ, Dr. Jutta Hansmann, Klein DS, Kranzh\u00f6fer DK, Kunz DB, Manegold DK, Dr. Andrea Penzkofer, Treml DK, Weg-Remers DS, Wittenberg DK, Baras N, Barnes DB, Bertz DJ, Buttmann-Schweiger N, Dahm DS, Julia Fiebig, Franke M, Haberland DJ, Kraywinkel DK, Wienecke A, Wolf DU. Krebs in Deutschland 2011\/2012. 10. Ausgabe. ed. Berlin: Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). 2015."},{"issue":"3","key":"10.1016\/j.suronc.2017.06.001_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00000658-200009000-00007","article-title":"Adenocarcinoma of the esophagogastric junction results of surgical therapy based on anatomical\/topographic classification in 1,002 consecutive patients","volume":"232","author":"Siewert","year":"2000","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.suronc.2017.06.001_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"lancet Oncol."},{"issue":"9813","key":"10.1016\/j.suronc.2017.06.001_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","article-title":"Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial","volume":"379","author":"Bang","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.suronc.2017.06.001_bib14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial","volume":"15","author":"Noh","year":"2014","journal-title":"lancet Oncol."},{"issue":"18","key":"10.1016\/j.suronc.2017.06.001_bib15","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"33","key":"10.1016\/j.suronc.2017.06.001_bib16","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2017.06.001_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"19","key":"10.1016\/j.suronc.2017.06.001_bib18","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","article-title":"Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection","volume":"30","author":"Smalley","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"9","key":"10.1016\/j.suronc.2017.06.001_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"lancet Oncol."},{"issue":"22","key":"10.1016\/j.suronc.2017.06.001_bib20","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.suronc.2017.06.001_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"13","key":"10.1016\/j.suronc.2017.06.001_bib22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2017.06.001_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000350935","article-title":"(Neo)-adjuvant chemo(-radio) therapy for adenocarcinomas of the gastroesophageal junction and the stomach in the West","volume":"30","author":"Wilke","year":"2013","journal-title":"Dig. Surg."},{"issue":"suppl 5","key":"10.1016\/j.suronc.2017.06.001_bib24","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2017.06.001_bib25","first-page":"461","article-title":"Awmf, Awmf. [German S3-guideline \u201cDiagnosis and treatment of esophagogastric cancer\u201d]","volume":"49","author":"Moehler","year":"2011","journal-title":"Z\u00a0Gastroenterol."},{"issue":"suppl 5","key":"10.1016\/j.suronc.2017.06.001_bib26","doi-asserted-by":"crossref","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","article-title":"Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Smyth","year":"2016","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2017.06.001_bib27","first-page":"1300","article-title":"Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: postoperative chemotherapy has a substantial impact on outcome","volume":"41","author":"Glatz","year":"2015","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2017.06.001_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/bjc.2012.588","article-title":"Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Br. J. cancer"},{"key":"10.1016\/j.suronc.2017.06.001_bib29","first-page":"781742","article-title":"The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas","volume":"2013","author":"Mirza","year":"2013","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2017.06.001_bib30","article-title":"Post-surgical chemotherapy versus surgery alone for resectable gastric cancer","volume":"9","author":"Diaz-Nieto","year":"2013","journal-title":"Cochrane database Syst. Rev. (Online)"},{"issue":"7","key":"10.1016\/j.suronc.2017.06.001_bib31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0959-8049(99)00076-3","article-title":"Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials","volume":"35","author":"Earle","year":"1999","journal-title":"Eur. J. Cancer"},{"issue":"17","key":"10.1016\/j.suronc.2017.06.001_bib32","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.2010.534","article-title":"Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis","volume":"303","author":"Group","year":"2010","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.suronc.2017.06.001_bib33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1200\/JCO.1993.11.8.1441","article-title":"Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials","volume":"11","author":"Hermans","year":"1993","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2017.06.001_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/11024150201680005","article-title":"Chemotherapy in gastric cancer: a review and updated meta-analysis","volume":"168","author":"Janunger","year":"2002","journal-title":"Eur. J. Surg.\u00a0= Acta Chir."},{"issue":"11","key":"10.1016\/j.suronc.2017.06.001_bib35","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ejso.2008.02.002","article-title":"An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer","volume":"34","author":"Liu","year":"2008","journal-title":"Eur. J. Surg. Oncol.: J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2017.06.001_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008377101672","article-title":"Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)","volume":"11","author":"Mari","year":"2000","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2017.06.001_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1179\/joc.2006.18.3.311","article-title":"Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan","volume":"18","author":"Oba","year":"2006","journal-title":"J.\u00a0Chemother."},{"issue":"1","key":"10.1016\/j.suronc.2017.06.001_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/bjs.6408","article-title":"Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer","volume":"96","author":"Sun","year":"2009","journal-title":"Br. J. Surg."},{"issue":"40","key":"10.1016\/j.suronc.2017.06.001_bib39","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.3748\/wjg.v17.i40.4542","article-title":"Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer","volume":"17","author":"Chen","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"48","key":"10.1016\/j.suronc.2017.06.001_bib40","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.3748\/wjg.v18.i48.7384","article-title":"Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric\/gastroesophageal cancer: a meta-analysis","volume":"18","author":"Ge","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MCG.0000000000000212","article-title":"Survival benefit of neoadjuvant chemotherapy for resectable cancer of the gastric and gastroesophageal junction: a meta-analysis","volume":"49","author":"Jiang","year":"2015","journal-title":"J.\u00a0Clin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib42","article-title":"Preoperative chemotherapy for resectable thoracic esophageal cancer","volume":"19","author":"Kidane","year":"2015","journal-title":"Cochrane database Syst. Rev. (Online)"},{"issue":"44","key":"10.1016\/j.suronc.2017.06.001_bib43","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.3748\/wjg.v16.i44.5621","article-title":"Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis","volume":"16","author":"Li","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jgh.12152","article-title":"Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials","volume":"28","author":"Liao","year":"2013","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.suronc.2017.06.001_bib45","unstructured":"Lublin MUo. The Role of Postoperative Chemotherapy Cycles in the Combined Modality Therapy of Gastric Cancer With Perioperative Chemotherapy and Surgery in Pathological Responders [Internet]. Bethesda (MD): National Library of Medicine (US); 2000-[cited 2017 Jan 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT01787539 NLM Identifier: NCT01787539."},{"issue":"15","key":"10.1016\/j.suronc.2017.06.001_bib46","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.ejca.2013.05.029","article-title":"Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data","volume":"49","author":"Ronellenfitsch","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.suronc.2017.06.001_bib47","doi-asserted-by":"crossref","first-page":"12850","DOI":"10.1038\/srep12850","article-title":"Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.suronc.2017.06.001_bib48","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"27","key":"10.1016\/j.suronc.2017.06.001_bib49","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"24","key":"10.1016\/j.suronc.2017.06.001_bib50","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2006.10.4760","article-title":"Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer","volume":"25","author":"Kelsen","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"9319","key":"10.1016\/j.suronc.2017.06.001_bib51","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial","volume":"359","author":"Medical Research Council Oesophageal Cancer Working Party","year":"2002","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.suronc.2017.06.001_bib52","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1200\/JCO.2009.26.6114","article-title":"Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954","volume":"28","author":"Schuhmacher","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.suronc.2017.06.001_bib53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12885-016-2708-0","article-title":"Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer","volume":"16","author":"Lichthardt","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2017.06.001_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.amjsurg.2014.12.036","article-title":"Impact of postoperative chemotherapy in patients with locally advanced gastroesophageal adenocarcinoma treated with perioperative chemotherapy strategy","volume":"210","author":"Luc","year":"2015","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.suronc.2017.06.001_bib55","article-title":"Post-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation. Gastric cancer","author":"Blank","year":"2014","journal-title":"Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc."},{"issue":"7","key":"10.1016\/j.suronc.2017.06.001_bib56","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/bjc.2014.94","article-title":"Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas","volume":"110","author":"Schmidt","year":"2014","journal-title":"Br. J. cancer"},{"issue":"2","key":"10.1016\/j.suronc.2017.06.001_bib57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/SLA.0b013e318216f449","article-title":"Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases","volume":"253","author":"Becker","year":"2011","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.suronc.2017.06.001_bib59","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/annonc\/mds129","article-title":"Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}","volume":"23","author":"Thuss-Patience","year":"2012","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2017.06.001_bib60","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"Al-Batran","year":"2016","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2017.06.001_bib61","first-page":"868","article-title":"Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer","volume":"16","author":"Biffi","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.suronc.2017.06.001_bib62","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.26180","article-title":"Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel","volume":"130","author":"Homann","year":"2012","journal-title":"Int. J. cancer"},{"issue":"10","key":"10.1016\/j.suronc.2017.06.001_bib63","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdm269","article-title":"Split-dose docetaxel, cisplatin and leucovorin\/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial","volume":"18","author":"Lorenzen","year":"2007","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2017.06.001_bib64","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/annonc\/mdr465","article-title":"Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial","volume":"23","author":"Ferri","year":"2012","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2017.06.001_bib65","first-page":"218","article-title":"Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma","volume":"43","author":"Kim","year":"2017","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2017.06.001_bib66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1245\/s10434-014-3875-3","article-title":"Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma","volume":"22","author":"Sudarshan","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib67","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1245\/s10434-014-4120-9","article-title":"Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma","volume":"22","author":"van der Sluis","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.suronc.2017.06.001_bib68","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13045-015-0148-y","article-title":"The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas","volume":"8","author":"Kim","year":"2015","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.suronc.2017.06.001_bib69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2407-13-281","article-title":"Phase II\/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19-FFCD1103-ADCI002","volume":"13","author":"Piessen","year":"2013","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib70","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/SLA.0b013e3182352647","article-title":"FRENCH Fwg-. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study","volume":"254","author":"Messager","year":"2011","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2017.06.001_bib71","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1245\/s10434-013-3462-z","article-title":"Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?","volume":"21","author":"Heger","year":"2014","journal-title":"Ann. Surg. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740417301196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740417301196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:18:27Z","timestamp":1760757507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740417301196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":71,"alternative-id":["S0960740417301196"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2017.06.001","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}